Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart  has been straight up and to the right, up 553% and ...

Eli Lilly announces that its weight loss drug, tirzepatide, has been approved by Chinese regulators. This move intensifies ...

Shares of Eli Lilly (LLY) are soaring after the pharmaceutical giant received regulatory approval in China for its GLP-1 ...

Eli Lilly (NYSE: LLY) announced on social media Friday that its weight loss drug, tirzepatide, has received approval from ...

The Dow Jones Industrial Average dropping nearly 1.3% to 40,665.03 on Thursday, the S&P 500 and Nasdaq declined as well.

U.S. pharmaceutical company Eli Lilly & Co.’s (LLY) weight loss medication called “Mounjaro” has been approved for use in ...

Eli Lilly (NYSE: LLY) has achieved a major milestone by securing regulatory approval for its weight management drug, Mounjaro ...

GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday ...

Eli Lilly said in a social media post Friday its weight loss drug tirzepatide had received approval from Chinese regulators, ...

There are dozens of promising biotech companies developing weight-loss drugs. Among the larger drug companies, Amgen and ...

Streaming giant Netflix (NFLX) is the hot stock today after the firm posted Q2 results. Unusually, markets did not react positively to the company’s 16.7% Y/Y revenue growth, to $9.56 billion. Netflix ...